Search | IOVS | ARVO Journals

View

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Fc Receptors involved in neuroprotective γ- Synuclein antibody transport into retinal Müller cells

Katharina Bell; Corina Wilding; Ines Rosignol; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6143. doi:

ARVO Annual Meeting Abstract June 2017

Efficacy and Safety of Preoperative IOP Reduction better for Preservative-free Fixed Combination of Dorzolamide/timolol Eye Drops versus Oral Acetazolamide and Dexamethasone Eye Drops for Outcome of Trabeculectomy

Katrin Lorenz; Joanna Wasielica-Poslednik; Katharina Bell; Guilia Renieri; Alexander Keicher; Christian Ruckes; Norbert Pfeiffer; Hagen Thieme

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2103. doi:

ARVO Annual Meeting Abstract June 2017

Neuroprotective antibodies trigger CNTF secretion of Müller cells

Katharina Bell; Corina Wilding; Sabine Beck; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2552. doi:

ARVO Annual Meeting Abstract June 2017

Main results of the First-In Human single ascending dose phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2) in glaucoma filtration surgery

Bogomil Voykov; Hagen Thieme; Katharina Bell; Melanie Weigel; Guilia Renieri; Barbara Wilhelm; Katrin Lorenz; Petra Fettes; Eugen Leo; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5577. doi:

ARVO Annual Meeting Abstract September 2016

Protein changes within the Rho pathway in neuroretinal cells after incubation with POAG serum: Cofilin, Rac1, CDC42 – causes for the effect of ROCK-inhibitors?

Madeleine Kiderle; Katharina Bell; Sebastian Funke; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5635. doi:

ARVO Annual Meeting Abstract September 2016

Mass spectrometric analysis of novel antibody-peptide sequences in glaucoma.

Carsten Schmelter; Natarajan Perumal; Sebastian Funke; Katharina Bell; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6018. doi:

ARVO Annual Meeting Abstract September 2016

Glutamine synthetase shift involved in protective effects of GFAP antibody on retinal ganglion cells

Katharina Bell; Corina Wilding; Jana Holz-Müller; Sebastian Funke; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2567. doi:

ARVO Annual Meeting Abstract June 2015

Gamma- synuclein antibodies have protective effect on retinal ganglion cells

Katharina Bell; Corina Wilding; Natarajan Perumal; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3667. doi:

ARVO Annual Meeting Abstract April 2014

Changed levels of CD4(+)CD25(+) T cells in glaucoma patients in comparison to healthy controls

Katharina Bell; Anna Holz; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5709. doi:

ARVO Annual Meeting Abstract April 2014

Participation of ERP57 in the pro-survival potential of GFAP abs on RGC5

Corina Wilding; Katharina Bell; Sebastian Funke; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2438. doi:

ARVO Annual Meeting Abstract June 2013

Protective effect of GFAP antibody on RGC5 cells via actin cytoskeleton pathways

Corina Wilding; Katharina Bell; Sebastian Funke; Sabine Beck; Norbert Pfeiffer; Franz Grus

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):432. doi:

ARVO Annual Meeting Abstract June 2013

Changes in antibodies from glaucoma patients lead to changes in apoptosis pathways of neuroretinal cells

Katharina Bell; Corina Wilding; Sebastian Funke; Norbert Pfeiffer; Franz Grus

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1605. doi:

ARVO Annual Meeting Abstract June 2013

In Depth Analysis of Retinal Proteins using a Combinatory HPLC based Mass Spectrometric Platform

Sebastian Funke; Dominik Wolters; Lukas Weiler; Francis Mwiiri; Katharina Bell; Corina Wilding; Norbert Pfeiffer; Franz Grus

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):698. doi:

ARVO Annual Meeting Abstract March 2012

Effect Of - Synuclein Antibody On Rgc5 And Mitochondrial Apoptosis Pathways

Corina Wilding; Katharina Bell; Franz Grus; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6591. doi:

ARVO Annual Meeting Abstract March 2012

Down Regulation Of 14-3-3 Ab In Glaucoma Patients Could Lead To Loss Of Protective Effects

Katharina Bell; Corina Wilding; Norbert Pfeiffer; Franz H. Grus

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6592. doi:

ARVO Annual Meeting Abstract April 2011

Protective Effect Of - synuclein Antibody On Stressed Retinal Ganglion Cells

Corina Wilding; Katharina Bell; Norbert Pfeiffer; Franz H. Grus

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3939. doi:

ARVO Annual Meeting Abstract April 2011

Up-regulation Of Protein Kinase C Inhibitor (14-3-3) In Retinal Ganglion Cells Incubated With Glaucoma Serum

Katharina Bell; Gail M. Seigel; Norbert Pfeiffer; Franz H. Grus

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4598. doi:

Advertisement